医药导报
醫藥導報
의약도보
Herald of Medicine
2015年
10期
1292-1295
,共4页
熊果酸%前列腺炎,非细菌性,慢性%酶联免疫吸附测定
熊果痠%前列腺炎,非細菌性,慢性%酶聯免疫吸附測定
웅과산%전렬선염,비세균성,만성%매련면역흡부측정
Ursolic acid%Prostatitis,nonbacterial,chronic%Enzyme-linked immuno-sorbent assay
目的:探讨熊果酸对角叉菜胶诱导的慢性非细菌性前列腺炎( CNP )大鼠的治疗作用及其机制。方法将42只斯泼累格??多雷( SD)大鼠随机分为正常对照组、模型对照组、普适泰组、熊果酸大剂量组和小剂量组,除正常对照组外,其他组造CNP模型。普适泰组灌胃给予普适泰药液148 mg??kg-1??d-1,熊果酸大剂量组和小剂量组分别灌胃给予熊果酸药液100和50 mg??kg-1??d-1,正常对照组和模型对照组灌胃给予等体积0.5%羧甲基纤维素钠溶液,连续给药20 d。考察大鼠的前列腺指数,利用酶联免疫吸附测定( ELISA)检测大鼠血清中白细胞介素-1β( IL-1β)、肿瘤坏死因子-α( TNF-α)和白细胞介素-10( IL-10)的水平,经苏木精-伊红( HE)染色观察前列腺组织的病理学变化。结果与模型对照组比较,熊果酸大剂量组、小剂量组大鼠前列腺指数显著降低(P<0.05),血液中细胞因子IL-1β、TNF-α和IL-10的水平下降(P<0.05或P<0.01)。前列腺组织切片HE染色显示熊果酸大剂量组前列腺炎病理组织学改变有明显的改善。结论熊果酸对角叉菜胶诱导的慢性非细菌性前列腺炎大鼠具有一定的治疗作用,其机制可能与熊果酸对IL-1β、TNF-α和IL-10水平的调节作用有关。
目的:探討熊果痠對角扠菜膠誘導的慢性非細菌性前列腺炎( CNP )大鼠的治療作用及其機製。方法將42隻斯潑纍格??多雷( SD)大鼠隨機分為正常對照組、模型對照組、普適泰組、熊果痠大劑量組和小劑量組,除正常對照組外,其他組造CNP模型。普適泰組灌胃給予普適泰藥液148 mg??kg-1??d-1,熊果痠大劑量組和小劑量組分彆灌胃給予熊果痠藥液100和50 mg??kg-1??d-1,正常對照組和模型對照組灌胃給予等體積0.5%羧甲基纖維素鈉溶液,連續給藥20 d。攷察大鼠的前列腺指數,利用酶聯免疫吸附測定( ELISA)檢測大鼠血清中白細胞介素-1β( IL-1β)、腫瘤壞死因子-α( TNF-α)和白細胞介素-10( IL-10)的水平,經囌木精-伊紅( HE)染色觀察前列腺組織的病理學變化。結果與模型對照組比較,熊果痠大劑量組、小劑量組大鼠前列腺指數顯著降低(P<0.05),血液中細胞因子IL-1β、TNF-α和IL-10的水平下降(P<0.05或P<0.01)。前列腺組織切片HE染色顯示熊果痠大劑量組前列腺炎病理組織學改變有明顯的改善。結論熊果痠對角扠菜膠誘導的慢性非細菌性前列腺炎大鼠具有一定的治療作用,其機製可能與熊果痠對IL-1β、TNF-α和IL-10水平的調節作用有關。
목적:탐토웅과산대각차채효유도적만성비세균성전렬선염( CNP )대서적치료작용급기궤제。방법장42지사발루격??다뢰( SD)대서수궤분위정상대조조、모형대조조、보괄태조、웅과산대제량조화소제량조,제정상대조조외,기타조조CNP모형。보괄태조관위급여보괄태약액148 mg??kg-1??d-1,웅과산대제량조화소제량조분별관위급여웅과산약액100화50 mg??kg-1??d-1,정상대조조화모형대조조관위급여등체적0.5%최갑기섬유소납용액,련속급약20 d。고찰대서적전렬선지수,이용매련면역흡부측정( ELISA)검측대서혈청중백세포개소-1β( IL-1β)、종류배사인자-α( TNF-α)화백세포개소-10( IL-10)적수평,경소목정-이홍( HE)염색관찰전렬선조직적병이학변화。결과여모형대조조비교,웅과산대제량조、소제량조대서전렬선지수현저강저(P<0.05),혈액중세포인자IL-1β、TNF-α화IL-10적수평하강(P<0.05혹P<0.01)。전렬선조직절편HE염색현시웅과산대제량조전렬선염병리조직학개변유명현적개선。결론웅과산대각차채효유도적만성비세균성전렬선염대서구유일정적치료작용,기궤제가능여웅과산대IL-1β、TNF-α화IL-10수평적조절작용유관。
Objective To investigate the therapeutic effect and mechanism of ursolic acid on carrageenan-induced chronic nonbacterial prostatitis (CNP) of SD rats. Methods Forty-two SD rats were randomly divided into five groups:normal control group, model control group, Pushitai group, ursolic acid high-dose group, and low-dose group.Except for normal control group, chronic nonbacterial prostatitis model was established using carrageenan. The rats of Pushitai group were treated with the solution of Pushitai at the dose of 148 mg??kg-1??d-1 for twenty days.The rats of ursolic acid high-dose and low-dose groups were administered with ursolic acid at the doses of 100 and 50 mg??kg-1??d-1 for twenty days, respectively. The rats of normal and model control groups were treated with isometric 5% CMC-Na for twenty days.The prostate index (PI) was calculated from the ratio of isolated rat prostate weight and body weight of rat.The expressions of IL-1β, TNF-α, and IL-10 were detected by ELISA. The histology and morphology of the prostate was observed with the aid of hematoxylin-eosin staining. Results Compared with the model control group, PI and the levels of IL-1β, TNF-α, and IL-10 in serum were significantly decreased in ursolic acid high-dose,and low dose groups ( P<0. 05 ) . Moreover, the pathological changes of prostate were improved significantly. Conclusion Ursolic acid has certain therapy effects on chronic nonbacterial prostatitis, which may be related to its regulating the expressions of IL-1β, TNF-α, and IL-10.